Every recall we track for Denton Pharma, Inc. — 4 in all, from 2019–2020 — plus the complaints and injury reports the public filed about them.
Recalls on record by year — 4 drug.
Denton Pharma recalls Metformin Hydrochloride Extended-Release Tablets (500mg) due to detected N-Nitrosodimethylamine (NDMA) impurity above safe levels. Affected products include 30-count, 60-count, 90-count, and 120-count bottles with specific NDC numbers and expiration dates.
Denton Pharma recalls 150mg ranitidine tablets with NDMA impurity detected. Products sold between 2021-2022 may pose health risks. Consumers should check product labels and contact manufacturer.
4 recalls from Denton Pharma, Inc. are on record with U.S. safety agencies, from 2019–2020.
Denton Pharma, Inc. recalls Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 30 count (NDC 70934-309-30); b) 60 count (NDC, dated Oct 8, 2020. Every Denton Pharma, Inc. recall is listed on this page, newest first.
The most common reasons on record: CGMP Deviations: Presence of NDMA impurity detected in product. (2).
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
